Literature DB >> 11507038

Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

S Gruvberger1, M Ringnér, Y Chen, S Panavally, L H Saal, M Fernö, C Peterson, P S Meltzer.   

Abstract

To investigate the phenotype associated with estrogen receptor alpha (ER) expression in breast carcinoma, gene expression profiles of 58 node-negative breast carcinomas discordant for ER status were determined using DNA microarray technology. Using artificial neural networks as well as standard hierarchical clustering techniques, the tumors could be classified according to ER status, and a list of genes which discriminate tumors according to ER status was generated. The artificial neural networks could accurately predict ER status even when excluding top discriminator genes, including ER itself. By reference to the serial analysis of gene expression database, we found that only a small proportion of the 100 most important ER discriminator genes were also regulated by estradiol in MCF-7 cells. The results provide evidence that ER+ and ER- tumors display remarkably different gene-expression phenotypes not solely explained by differences in estrogen responsiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507038

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  212 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

Review 2.  Statistics in clinical trials.

Authors:  Stephanie J Green; Donna K Pauler
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

3.  Combining gene expression and molecular marker information for mapping complex trait genes: a simulation study.

Authors:  Miguel Pérez-Enciso; Miguel A Toro; Michel Tenenhaus; Daniel Gianola
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

4.  Coexpression analysis of human genes across many microarray data sets.

Authors:  Homin K Lee; Amy K Hsu; Jon Sajdak; Jie Qin; Paul Pavlidis
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

Review 5.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

6.  Higher levels of GATA3 predict better survival in women with breast cancer.

Authors:  Nam K Yoon; Erin L Maresh; Dejun Shen; Yahya Elshimali; Sophia Apple; Steve Horvath; Vei Mah; Shikha Bose; David Chia; Helena R Chang; Lee Goodglick
Journal:  Hum Pathol       Date:  2010-12       Impact factor: 3.466

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  E4F1, a novel estrogen-responsive gene in possible atheroprotection, revealed by microarray analysis.

Authors:  Yasuhiro Nakamura; Katsuhide Igarashi; Takashi Suzuki; Jun Kanno; Tohru Inoue; Chika Tazawa; Masayuki Saruta; Tomoko Ando; Noriko Moriyama; Toru Furukawa; Masao Ono; Takuya Moriya; Kiyoshi Ito; Haruo Saito; Tadashi Ishibashi; Shoki Takahashi; Shogo Yamada; Hironobu Sasano
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 9.  Clinical utility of gene-expression signatures in early stage breast cancer.

Authors:  Maryann Kwa; Andreas Makris; Francisco J Esteva
Journal:  Nat Rev Clin Oncol       Date:  2017-05-31       Impact factor: 66.675

Review 10.  Carbonic anhydrase XII functions in health and disease.

Authors:  Abdul Waheed; William S Sly
Journal:  Gene       Date:  2017-04-19       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.